China’s healthcare market is expected to be worth US$2.4 trillion by 2030
Mainland China’s healthcare sector has strong investment prospects for 2018 and beyond, according to Joseph Jimenez, who has just stepped down as CEO of healthcare giant Novartis. “China has the infrastructure, the talent and government support—as well as high medical need—to be a thriving market for healthcare innovation,” he says.
See also: More Than Meat: Impossible Foods’ David Lee And Nick Halla On The Future Of Plant-Based Food
Why? Because China is getting old. What’s more, the world’s youngest superpower is projected to become the world’s most aged society by 2037. More than 143 million Chinese residents were over the age of 65 in 2017, about 10 per cent of the population. Twenty years later, that proportion is forecast to double, according to the United Nations.
Given these statistics, it’s hardly surprising that in recent years the Chinese government has increased spending on pensions and social security, which in turn has produced a relatively affluent constituency of elderly consumers. This silver-haired segment of society is driving increased demand for senior care services, though the country’s public health system has struggled to keep up with their rising expectations. The per-capita health expenditure in the People’s Republic of China is still very low relative to that of the United States (US$9,892 versus US$733 in the PRC in 2016), and there is huge potential for additional spending increases, both public and private, especially in such areas as independent senior living facilities, skilled nursing facilities, and services that cater to age-related health problems such as cancer, diabetes, heart disease, hypertension and respiratory illness.
See also: Health & Wealth: Healthcare Investment